The Wharton Moneyball Post Game Podcast


Wharton Moneyball: Super Bowl 2019, NBA Playoffs, & Australian Open

Ep. 135

Show from 1/30/19

In this episode of Wharton Moneyball our hosts get prepped for the 2019 Super Bowl! They have on former NFL Fullback and Tight End Erik Lorig to discuss the team dynamics of a Super Bowl. Lorig played for the New Orleans Saints and the Tampa Bay Buccaneers. "Defensive lines win Super Bowls. That position has the power to really affect an offensive play," according to Lorig. Then more football analytics with Aaron Schatz of Plus some NBA playoffs, Australian Open, and golf. All that and more.


Erik Lorig is a former NFL fullback and tight end where he played for the Buccaneers and Saints after converting from a defensive lineman where he played at Stanford. Erik is currently a fulltime MBA student here at Wharton where he is focusing his studies on Business Analytics and Entrepreneurship

Follow him on Twitter @erikalexander41

Aaron Schatz launched the football analytics website in July 2003. He remains editor-in-chief and head statistician for the website as well as the book series “Football Outsiders Almanac”. He also writes for and ESPN The Magazine and appears weekly during the season on the Off The Charts podcast. 

Follow him on Twitter @FO_ASchatz

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.